New CAR T therapy targets fusion-driven solid tumors via GPNMB
Chimeric antigen receptor T cell therapy has transformed the treatment of certain blood cancers, delivering remissions in patients with leukemia ...
Chimeric antigen receptor T cell therapy has transformed the treatment of certain blood cancers, delivering remissions in patients with leukemia ...
Physician-scientist Theodore Scott Nowicki, MD, PhD, an assistant professor in the departments of pediatrics hematology/oncology and microbiology, immunology, & molecular ...
At the forefront of cancer innovation, researchers from Memorial Sloan Kettering Cancer Center (MSK) showcased groundbreaking advancements at the 2026 ...
A groundbreaking advancement in cancer immunotherapy has emerged from the laboratories of Memorial Sloan Kettering Cancer Center (MSK), where scientists ...
A groundbreaking development in immunotherapy from UCLA scientists has unveiled a next-generation chimeric antigen receptor T-cell (CAR-T) therapy engineered to ...
In recent years, CAR T cell therapy has emerged as a groundbreaking approach in the fight against blood cancers, demonstrating ...
In the landscape of cancer immunotherapy, chimeric antigen receptor (CAR) T cell therapies have revolutionized treatment paradigms for hematological malignancies. ...
In a groundbreaking revelation within the field of cancer therapy, researchers have pioneered a method that significantly enhances the efficacy ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine